Abstract: 2018 witnessed the rational development of China's biopharmaceutical industry. In 2019, with the changes in political and economic environment, biopharmaceutical enterprises will enter a new period of adjustment. At the beginning of 2019, Shanghai Center for Innovation Drug Discovery and Development (SCIDDD) held a series of roundtable brainstorming, and proposed the 2019 outlook of China's biopharmaceutical industry, emphasizing that biopharmaceutical enterprises need to find a new balance between survival and development.